Corticosteroids are among the most effective tools for bringing active inflammatory bowel disease (IBD) under control quickly. Many patients with Crohn’s disease or ulcerative colitis will be prescribed them during a flare. Yet steroids are not intended for long-term use, and stopping them safely requires planning. Understanding when they help, how to taper off, and how to manage their side effects can make this phase of treatment less daunting.
What Are Corticosteroids and How Do They Work?
Corticosteroids are synthetic versions of cortisol, a hormone produced naturally by the adrenal glands. In IBD, they rapidly suppress the immune system and reduce gut inflammation. Common examples include prednisolone, prednisone, budesonide, and hydrocortisone.
Steroids work by blocking multiple inflammatory pathways. They inhibit cytokine production, which drives immune activity, and reduce white blood cell recruitment to the gut lining. This broad suppression helps relieve diarrhoea, pain, and bleeding whilst allowing gut tissue to heal.
Budesonide is a modified steroid acting mainly in the gut and broken down quickly by the liver, resulting in fewer body-wide effects. It is often used in mild to moderate Crohn’s disease affecting the ileum or right colon. Prednisolone and prednisone are systemic steroids affecting the whole body, typically used when inflammation is more severe or widespread.
When Steroids Are Helpful in IBD
Steroids are most useful during moderate to severe flares when inflammation needs rapid control. They are unsuitable for maintaining remission because of side effects with prolonged use.
Inducing Remission
Steroids effectively bring active disease under control within days to weeks. They reduce symptoms, calm inflammation, and improve quality of life whilst longer-term therapies such as immunosuppressants or biologics are started or adjusted.
Bridging Therapy
Because immunosuppressants and biologics can take weeks or months to reach full effect, steroids provide relief whilst waiting for maintenance treatment to take over.
Not for Maintenance
Steroids do not prevent flares or maintain long-term remission. Keeping someone on steroids beyond three months increases serious side effect risk without improving outcomes. If symptoms return as the dose reduces, this usually signals inadequate maintenance therapy.
How to Come Off Steroids Safely
Stopping steroids suddenly after using them for more than a week or two can be dangerous. When synthetic steroids are taken regularly, the adrenal glands reduce their own cortisol production. Abrupt discontinuation can leave the body without enough cortisol to cope with stress, leading to adrenal insufficiency, a potentially serious condition.
Tapering
Tapering means gradually reducing the dose over weeks or months to allow the adrenal glands time to resume normal function. The pace depends on the dose, treatment duration, and patient response.
A typical taper might start at 40 mg prednisolone daily, reducing by 5 mg weekly until reaching 20 mg, then by 2.5 mg weekly until 10 mg, and finally by 1 mg weekly. Slower tapers are sometimes needed if symptoms return or if steroids have been used for several months.
Monitoring Symptoms During Tapering
Some fatigue or mild discomfort as the dose reduces is common and does not always mean the IBD is flaring. Distinguishing between steroid withdrawal symptoms and active inflammation can be difficult. If symptoms worsen significantly, blood tests such as C-reactive protein (CRP) or faecal calprotectin, and sometimes imaging or endoscopy, may be needed.
Adjusting Maintenance Therapy
If disease symptoms return during tapering, the underlying IBD is likely not adequately controlled. The maintenance treatment may need changing or escalating rather than restarting the steroid at a higher dose.
Managing the Side Effects of Steroids
Steroids are powerful but come with a broad range of side effects, especially with longer use. Understanding these helps patients and clinicians manage them proactively.
Mood and Sleep Changes
Steroids can cause mood swings, irritability, anxiety, and sleep difficulty. Some people feel energised or restless, particularly in the evening. Taking the full daily dose in the morning can help with sleep. Severe mood disturbances should be discussed with a healthcare professional.
Increased Appetite and Weight Gain
Steroids stimulate appetite and promote fat deposition, particularly around the face, neck, and abdomen. Weight gain usually reverses after stopping. Focusing on nutrient-dense, lower-energy foods and staying active within comfort can help limit excess weight.
Blood Sugar and Diabetes Risk
Steroids increase blood glucose levels and can unmask or worsen diabetes. Blood sugar monitoring may be advised, particularly in those with risk factors. Reducing refined carbohydrates and sugary foods may help manage glucose levels.
Bone Health
Prolonged steroid use increases osteoporosis and fracture risk. Patients on steroids for more than three months should be assessed for bone protection, which may include calcium and vitamin D supplementation, and sometimes bisphosphonates.
Infection Risk
Steroids suppress the immune system, increasing infection susceptibility. Patients should avoid live vaccines whilst on steroids and seek prompt medical advice if they develop fever or infection signs.
Skin Changes
Skin thinning, easy bruising, and delayed wound healing are common. Stretch marks, particularly on the abdomen and thighs, may also appear and can be permanent.
Eye Problems
Long-term steroid use is associated with cataracts and increased eye pressure (glaucoma). Regular eye checks may be recommended for those on repeated or prolonged courses.
Practical Takeaways
- Steroids are effective for controlling flares but should not be used long term.
- Always taper steroids gradually under medical supervision; never stop suddenly.
- Distinguish between steroid withdrawal symptoms and returning IBD activity with your healthcare team.
- If you cannot come off steroids without symptoms returning, your maintenance therapy may need reviewing.
- Take your daily steroid dose in the morning to reduce sleep disturbance.
- Focus on bone health with calcium, vitamin D, and weight-bearing activity if possible.
- Monitor for mood changes, blood sugar rises, and infections, and report concerns early.
Conclusion
Steroids remain a vital tool in IBD management, offering rapid relief during flares and bridging patients to effective long-term therapy. Coming off them safely requires a gradual taper and careful symptom monitoring. Managing side effects involves anticipation, practical adjustments, and close communication with healthcare professionals. Steroids are not the goal of treatment, but when used appropriately and for a limited time, they can help regain control and move towards stable remission.
References
- Lichtenstein GR, Loftus EV, Isaacs KL, et al. ACG clinical guideline: management of Crohn’s disease in adults. Am J Gastroenterol. 2018;113(4):481-517. doi:10.1038/ajg.2018.27
- Rubin DT, Ananthakrishnan AN, Siegel CA, et al. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114(3):384-413. doi:10.14309/ajg.0000000000000152
- Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60(5):571-607. doi:10.1136/gut.2010.224154
- Toruner M, Loftus EV, Harmsen WS, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology. 2008;134(4):929-936. doi:10.1053/j.gastro.2008.01.012
- Steinhart AH, Ewe K, Griffiths AM, et al. Corticosteroids for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev. 2003;(4):CD000301. doi:10.1002/14651858.CD000301
- Buckley L, Guyatt G, Fink HA, et al. 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol. 2017;69(8):1521-1537. doi:10.1002/art.40137
- Seibold F, Fournier N, Beglinger C, et al. Topical therapy is underused in patients with ulcerative colitis. J Crohns Colitis. 2014;8(1):56-63. doi:10.1016/j.crohns.2013.03.005
- Van Staa TP, Leufkens HG, Abenhaim L, et al. Use of oral corticosteroids in the United Kingdom. QJM. 2000;93(2):105-111. doi:10.1093/qjmed/93.2.105
This article is intended for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for professional medical guidance, diagnosis, or treatment.